Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
CTD_human |
Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
|
7713310 |
1995 |
Diabetic Nephropathy
|
0.390 |
Therapeutic
|
disease |
CTD_human |
Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats.
|
7987072 |
1994 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
CTD_human |
L-dopa and streptozotocin-induced diabetic nephropathy in rats.
|
2143390 |
1990 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
The insertion/deletion (I/D) polymorphism of the angiotensin-converting-enzyme (ACE) gene has been reported to be associated with diabetic nephropathy in IDDM.
|
9660089 |
1998 |
Diabetic Nephropathy
|
0.390 |
Therapeutic
|
disease |
CTD_human |
L-dopa and streptozotocin-induced diabetic nephropathy in rats.
|
2143390 |
1990 |
Diabetic Nephropathy
|
0.390 |
Therapeutic
|
disease |
CTD_human |
Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
|
7713310 |
1995 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
CTD_human |
Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats.
|
7987072 |
1994 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
Enhanced erythrocyte Na+/H+ exchange predicts diabetic nephropathy in patients with IDDM.
|
9498654 |
1998 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
We studied plasma renin, prorenin, and four polymorphic markers of the renin gene in 199 patients with IDDM and DN, and in 192 normoalbuminuric IDDM controls matched for age, sex, and duration of diabetes.
|
10462269 |
1999 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM.
|
8772723 |
1996 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
IDDM subjects were divided into 2 groups according to the presence or absence of diabetic nephropathy (with nephropathy: n = 31, without nephropathy: n = 28).
|
8854649 |
1996 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
The role of the I/D polymorphism in the pathogenesis of diabetic nephropathy in IDDM is unresolved.
|
10099885 |
1999 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
In the following review, we examine the available clinical, epidemiologic and family studies to assess the relationship between the development of hypertension and diabetic nephropathy in IDDM and NIDDM.
|
9649955 |
1998 |
Diabetic Nephropathy
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
We investigated the changes of renal structure and its function in normal glucose tolerance (NGT), impaired glucose tolerance (IGT), diabetes mellitus (DM), and diabetic kidney disease (DKD) stages in OLETF rats and explored the role of the INS/IRS-1/PI3-K/Akt signaling pathway.
|
31737684 |
2019 |
Diabetic Nephropathy
|
0.390 |
Biomarker
|
disease |
BEFREE |
In conclusion, familial predisposition to essential hypertension increases the risk of diabetic nephropathy and may also contribute to the development of systemic hypertension in patients with IDDM and diabetic nephropathy.
|
9519751 |
1998 |